miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
1 Online-Ressource.
- Sprache
-
Englisch
- Erschienen in
-
miR-182, miR-221 and miR-222 are potential urinary extracellular vesicle biomarkers for canine urothelial carcinoma ; volume:14 ; number:1 ; day:2 ; month:8 ; year:2024 ; pages:1-11 ; date:12.2024
Scientific reports ; 14, Heft 1 (2.8.2024), 1-11, 12.2024
- Urheber
-
Karttunen, Jenni
Kalmar, Lajos
Grant, Andrew
Ying, Jun
Stewart, Sarah E.
Wang, Xiaonan
Frankl, Fiona Karet
Williams, Tim
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-024-69070-7
- URN
-
urn:nbn:de:101:1-2410242113453.045118943766
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:25 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Karttunen, Jenni
- Kalmar, Lajos
- Grant, Andrew
- Ying, Jun
- Stewart, Sarah E.
- Wang, Xiaonan
- Frankl, Fiona Karet
- Williams, Tim
- SpringerLink (Online service)
Ähnliche Objekte (12)
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
miR
MiR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
miR
MiR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms
Zirkulierende microRNAs miR-27b, miR-141, miR-191, miR-222 und miR-433 als relevante Faktoren der Implantation bei Patientinnen mit Polyzistischem Ovar-Syndrom
Clinical relevance of microRNA miR-21, miR-31, miR-92a, miR-101, miR-106a and miR-145 in colorectal cancer
miR
MiR
Interactions of miR-323/miR-326/miR-329 and miR-130a/miR-155/miR-210 as prognostic indicators for clinical outcome of glioblastoma patients
MicroRNAs miR-19, miR-340, miR-374 and miR-542 regulate MID1 protein expression
Microvesicle-associated and circulating microRNAs in diabetic dyslipidemia: miR-218, miR-132, miR-143, and miR-21, miR-122, miR-155 have biomarker potential
Zu MiR
Serum levels of miR-29, miR-122, miR-155 and miR-192 are elevated in patients with cholangiocarcinoma
Identification of miR-10b, miR-26a, miR-146a and miR-153 as potential triple-negative breast cancer biomarkers
Expression of miR-1, miR-133a, miR-133b and miR-206 increases during development of human skeletal muscle
Methylation of miR-34a, miR-34b/c, miR-124-1 and miR-203 in Ph-negative myeloproliferative neoplasms